|Bid||25.80 x 1800|
|Ask||25.81 x 800|
|Day's Range||25.62 - 26.07|
|52 Week Range||25.47 - 48.77|
|Beta (3Y Monthly)||1.06|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 31, 2019 - Aug 5, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||34.85|
MEDNAX Inc NYSE:MDView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is low for MD with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $2.28 billion over the last one-month into ETFs that hold MD are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
MEDNAX, Inc. (MD), today announced its affiliation with Central Coast Perinatal Medical Group, Inc., a private maternal-fetal medicine practice based in Santa Barbara, Calif. Founded in 1993, Central Coast Perinatal is an established group that has provided perinatal services to the Central Coast community for more than 25 years. Comprising three physicians, the practice specializes in care for expectant mothers, including those with high-risk pregnancies.
Mednax (MD) delivered earnings and revenue surprises of -8.45% and -5.89%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
The Sunrise, Florida-based company said it had a loss of $2.81 per share. Earnings, adjusted for one-time gains and costs, were 65 cents per share. The results fell short of Wall Street expectations. The ...
Results Reflect Classification of MedData as Discontinued Operations
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! After MEDNAX, Inc.'s (NYSE:MD) recent earnings announcement in December 2018...
"October lived up to its scary reputation—the S&P 500 falling in the month by the largest amount in the last 40 years, the only worse Octobers being '08 and the Crash of '87\. For perspective, there have been only 5 occasions in those 40 years when the S&P 500 declined by greater than 20% from […]
Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MEDNAX, Inc. (MD), will host an investor conference call and webcast on Thursday, May 2, 2019 at 10:00 a.m. ET, to discuss results from operations for the three months ended March 31, 2019. The investor conference call will be webcast and can be accessed at MEDNAX’s website, www.mednax.com/investors. MEDNAX, Inc. is a national health solutions partner comprised of the nation's leading providers of physician services.
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! The latest earnings release MEDNAX, Inc.'s (NYSE:MD) announced in December 2018 showed that the...
CVS Health Corp, Walgreens Boots Alliance Inc., Mednax Inc. and Amdocs Ltd. have declined to their respective three-year lows
MEDNAX, Inc. (MD), today announced its affiliation with Georgia Neonatology, LLC, a private neonatology practice based in Athens, Ga. Georgia Neonatology has provided neonatology services to Piedmont Healthcare’s Piedmont Athens Regional Medical Center location since 2013. The practice specializes in neonatal care for pre-term newborns and critically ill babies.
MEDNAX, Inc. (MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, other pediatric services, and management services, today announced the nomination of Carlos A. Migoya and Michael A. Rucker to stand for election to the Company’s Board of Directors at its Annual Meeting of Shareholders on May 16, 2019. As previously announced, MEDNAX’s Board and its Nominating and Corporate Governance Committee initiated a process, with the support of the nationally-recognized executive search firm Spencer Stuart, to evaluate the Board’s composition and identify additional director candidates to help drive MEDNAX’s strategy.
UBS Group AG (UBS), AutoNation Inc. (AN), Mednax Inc. (MD) and Amdocs Ltd. (DOX) have declined to three-year lows. The price of UBS Group shares declined to $11.88 on March 22, which is only 2.3% above the three-year low of $11.61. UBS is a Swiss investment bank and financial services company.
Announcement: Moody's announces completion of a periodic review of ratings of MEDNAX, Inc. New York, March 22, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of MEDNAX, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
Many investors define successful investing as beating the market average over the long term. But its virtually certain that sometimes you will buy stocks that fall short of the marketRead More...